iNOS Gene Transfer for Graft Disease
Authors:
- Edith TzengETEdith Tzeng
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 14 (7) , 267-272
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented modelMolecular Therapy, 2003
- Preclinical Evaluation of Inducible Nitric Oxide Synthase Lipoplex Gene Therapy for Inhibition of Stent-Induced Vascular Neointimal Lesion FormationHuman Gene Therapy, 2003
- Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein graftsSurgery, 1999
- Vascular inducible nitric oxide synthase gene therapy: Requirement for guanosine triphosphate cyclohydrolase ISurgery, 1996
- INHIBITION OF INTIMAL HYPERPLASIA IN RAT AORTIC ALLOGRAFTS WITH CYCLOSPORINETransplantation, 1995
- Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.Journal of Clinical Investigation, 1994
- Prevention of hemodialysis fistula thrombosis. Early detection of venous stenosesKidney International, 1989
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Functional Abnormalities of Experimental Autogenous Vein Graft NeoendotheliumAnnals of Surgery, 1988
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMThe Lancet, 1987